Mental health disorders and solid-organ transplant recipients

Transplantation

Volumn 96, Issue 7, 2013, Pages 593-600

  Corbett, Chris ^a,b   Armstrong, Matthew J ^a,b   Parker, Richard ^a,b   Webb, Kerry ^b   Neuberger, James M ^b,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Depression; Mental health; Psychosis; Transplantation

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CYCLOSPORIN; HYDROCORTISONE; HYPERICUM PERFORATUM EXTRACT; METHYLPREDNISOLONE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; TACROLIMUS;

ACUTE PSYCHOSIS; AGITATION; ANXIETY; ANXIETY DISORDER; BEHAVIOR DISORDER; COGNITIVE DEFECT; DECISION MAKING; DELIRIUM; DELUSION; DEPRESSION; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; EUPHORIA; EVIDENCE BASED MEDICINE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAPEFRUIT JUICE; HALLUCINATION; HEADACHE; HEALTH CARE; HEART TRANSPLANTATION; HUMAN; HYPOMANIA; INSOMNIA; INTELLIGENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MASS SCREENING; MEDICAL ETHICS; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MENTAL STRESS; MOOD DISORDER; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NUTRITIONAL DEFICIENCY; ORGAN TRANSPLANTATION; PHOBIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; SOCIAL SUPPORT; TREATMENT CONTRAINDICATION; TREATMENT REFUSAL; TREMOR; UNSPECIFIED SIDE EFFECT;

COMORBIDITY; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MENTAL DISORDERS; MENTAL HEALTH; PATIENT COMPLIANCE; PATIENT SELECTION; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885428422     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829584e0     Document Type: Review

References (60)

1. Schulz R, Beach SR, Ives DG, et al. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2000; 160: 1761.
2. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407.
3. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006; 25: 1024.
4. Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998; 66: 951.
5. Dudley C, Harden P. Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient. Nephron Clin Pract 2011; 118: c209.
6. Delvin J, O'Grady J. Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut 1999; 45: VI1.
7. Kalble T, Alcaraz A, Budde K, et al. Gudelines on renal transplantation. Available at: http://www.uroweb.org/gls/pdf/26-Renal-Transplant-LR.pdf. Accessed December 1, 2012.
8. Owen JE, Bonds CL, Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics 2006; 47: 213.
9. Rosenberger EM, Dew MA, Crone C, et al. Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation. Curr Opin Organ Transplant 2012; 17: 188.
10. Favaro A, Gerosa G, Caforio AL, et al. Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hosp Psychiatry 2011; 33: 1.
11. Oerlemans ME, van den Akker M, Schuurman AG, et al. A meta-analysis on depression and subsequent cancer risk Clin Pract Epidemiol Ment Health 2007; 3: 29.
12. Chida Y, Hamer M, Wardle J, et al. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 2008; 5: 466.
13. Lawlor DA, Juni P, Ebrahim S, et al. Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer. J Clin Epidemiol 2003; 56: 155.
14. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: 617.
15. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005; 5: 243.
16. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006; 6: 240.
17. Corruble E, Barry C, Varescon I, et al. Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res 2011; 71: 32.
18. DiMartini A, Dew MA, Chaiffetz D, et al. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant 2011; 11: 1287.
19. Rogal SS, Landsittel D, Surman O, et al. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl 2011; 17: 251.
20. Havik OE, Sivertsen B, Relbo A, et al. Depressive symptoms and all-cause mortality after heart transplantation. Transplantation 2007; 84: 97.
21. Spaderna H, Mendell NR, Zahn D, et al. Social isolation and depression predict 12-month outcomes in the ''waiting for a new heart study''. J Heart Lung Transplant 2010; 29: 247.
22. Evon DM, Burker EJ, Galanko JA, et al. Depressive symptoms and mortality in lung transplant. Clin Transplant 2010; 24: E201.
23. Vermeulen KM, TenVergert EM, Verschuuren EA, et al. Pre-transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant 2008; 27: 623.
24. Zalai D, Szeifert L, Novak M. Psychological distress and depression in patients with chronic kidney disease. Semin Dial 2012; 25: 428.
25. Akman B, Ozdemir FN, Sezer S, et al. Depression levels before and after renal transplantation. Transplant Proc 2004; 36: 111.
26. Novak M, Molnar MZ, Szeifert L, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 2010; 72: 527.
27. Olbrisch ME, Levenson JL. Psychosocial evaluation of heart transplant candidates: an international survey of process, criteria, and outcomes. J Heart Lung Transplant 1991; 10: 948.
28. Miller LW. Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians-National Institutes of Health conference. Transplantation 1998; 66: 947.
29. Triffaux JM, Wauthy J, Bertrand J, et al. Psychological evolution and assessment in patients undergoing orthotopic heart transplantation. Eur Psychiatry 2001; 16: 180.
30. Taborda JG, Bordignon S, Bertolote JM, et al. Heart transplantation and schizophrenia. Psychosomatics 2003; 44: 264.
31. DiMartini A, Twillman R. Organ transplantation and paranoid schizophrenia. Psychosomatics 1994; 35: 159.
32. Coffman K, Crone C. Rational guidelines for transplantation in patients with psychotic disorders. Curr Opin Organ Transplant 2002; 7: 385.
33. Tanriverdi N, Ozcurumez G, Colak T, et al. Quality of life and mood in renal transplantation recipients, donors, and controls: preliminary report. Transplant Proc 2004; 36: 117.
34. Dew MA, DiMartini AF, DeVito Dabbs AJ, et al. Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry 2012; 34: 127.
35. Parekh PI, Blumenthal JA, Babyak MA, et al. Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest 2003; 124: 1682.
36. Stilley CS, Dew MA, Stukas AA, et al. Psychological symptom levels and their correlates in lung and heart-lung transplant recipients. Psychosomatics 1999; 40: 503.
37. Nickel R, Wunsch A, Egle UT, et al. The relevance of anxiety, depression, and coping in patients after liver transplantation. Liver Transpl 2002; 8: 63.
38. DiMartini A, Crone C, Fireman M, et al. Psychiatric aspects of organ transplantation in critical care. Crit Care Clin 2008; 24: 949.
39. Trumper A, Appleby L. Psychiatric morbidity in patients undergoing heart, heart and lung, or lung transplantation. J Psychosom Res 2001; 50: 103.
40. DiMartini A, Dew MA, Kormos R, et al. Posttraumatic stress disorder caused by hallucinations and delusions experienced in delirium. Psychosomatics 2007; 48: 436.
41. Cuthbertson BH, Hull A, Strachan M, et al. Post-traumatic stress disorder after critical illness requiring general intensive care. Intensive Care Med 2004; 30: 450.
42. Olbrisch ME, Benedict SM, Ashe K, et al. Psychological assessment and care of organ transplant patients. J Consult Clin Psychol 2002; 70: 771.
43. Stukas AA Jr, Dew MA, Switzer GE, et al. PTSD in heart transplant recipients and their primary family caregivers. Psychosomatics 1999; 40: 212.
44. Rothenhausler HB, Ehrentraut S, Kapfhammer HP, et al. Psychiatric and psychosocial outcome of orthotopic liver transplantation. Psychother Psychosom 2002; 71: 285.
45. Jin SG, Yan LN, Xiang B, et al. Posttraumatic stress disorder after liver transplantation. Hepatobiliary Pancreat Dis Int 2012; 11: 28.
46. Dew MA, Kormos RL, Roth LH, et al. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549.
47. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000; 13: 313.
48. Wijdicks EF, Dahlke LJ, Wiesner RH. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients. Neurology 1999; 52: 1708.
49. Wijdicks EF, Wiesner RH, Krom RA. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 1995; 45: 1962.
50. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983; 5: 319.
51. Brown ES. An epidemiological approach to ''steroid psychosis''. Am J Psychiatry 2012; 169: 447.
52. Dew MA, Kormos RL, DiMartini AF, et al. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics 2001; 42: 300.
53. Klapheke MM. The role of the psychiatrist in organ transplantation. Bull Menninger Clin 1999; 63: 13.
54. Engle D. Psychosocial aspects of the organ transplant experience: what has been established and what we need for the future. J Clin Psychol 2001; 57: 521.
55. Morana JG. Psychological evaluation and follow-up in liver transplantation. World J Gastroenterol 2009; 15: 694.
56. Gross CR, Kreitzer MJ, Thomas W, et al. Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med 2010; 16: 30.
57. Barbour KA, Blumenthal JA, Palmer SM. Psychosocial issues in the assessment and management of patients undergoing lung transplantation. Chest 2006; 129: 1367.
58. Napolitano MA, Babyak MA, Palmer S, et al. Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation. Chest 2002; 122: 1176.
59. Fusar-Poli P, Picchioni M, Martinelli V, et al. Anti-depressive therapies after heart transplantation. J Heart Lung Transplant 2006; 25: 785.
60. Cherkassky L. A fair trial? Assessment of liver transplant candidates with psychiatric illnesses. J Med Ethics 2011; 37: 739.